Novo Nordisk: Is This An Overreaction Or The End Of The GLP-1 Fairy Tale?
Source: SeekingAlpha
2025-07-30 09:00:00 ET
Introduction
The market was shaken yesterday by the news of a Novo Nordisk A/S ( NVO ) 20% drop in a single day. A 1-year decline is getting close to 60%, and it sounds disproportionate, especially when reminded we are talking about the company that gave this world Ozempic. The Ozempic that almost every person in the world has heard about. And investors are quick to say this is an overreaction. But let’s pause for a second, is it really?...
Read the full article on Seeking Alpha
For further details see:
Novo Nordisk: Is This An Overreaction Or The End Of The GLP-1 Fairy Tale?
Innovent Biologics Inc
NASDAQ: IVBXF
IVBXF Trading
0.0% G/L:
$10.53 Last:
480 Volume:
$10.53 Open:
